Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Form SC 13G/A WHITE MOUNTAINS INSURANC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Enstar Group LTD Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Huazhu Group Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ContextLogic Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Tarena International, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Payoneer to Become Publicly Traded Company Through Combination With FTAC Olympus Acquisition Corporation (FTOCU) (FTOC)
-
Payoneer to Become Publicly Traded Company Through Combination With FTAC Olympus Acquisition Corporation
-
Form SC 13G Gritstone Oncology, Inc. Filed by: Wellington Management Portfolios (Dublin) Public Ltd Co
-
Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders
-
Latch to Merge with Tishman Speyer-Sponsored SPAC (TSIAU) (TSIA) and Become Publicly Listed Company
-
Latch, Maker of Full-Building Enterprise SaaS Platform LatchOS, to Merge with Tishman Speyer-Sponsored SPAC and Become Publicly Listed Company
-
CI Global Asset Management Funds and ETFs Recognized for Performance by FundGrade® A+ Awards
-
EVgo to Publicly List through Business Combination with Climate Change Crisis Real Impact I Acquisition Corporation (CLII)
-
EVgo, an LS Power Company, and Leader in U.S. Electric Vehicle Fast Charging, to Publicly List through Business Combination with Climate Change Crisis Real Impact I Acquisition Corporation
-
PPRO Raises $180 Million for the Next Era of Local Payments Infrastructure, Is Now Valued Over $1 Billion
-
Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease
-
Statement of the Ad Hoc Bondholder Group of the Province of Cordoba in Support of Amended Consent Solicitation
-
Verve Therapeutics Announces Data Demonstrating Durable LDL Cholesterol Lowering After a One-Time Gene Editing Treatment in Non-Human Primates
-
Form SC 13G/A OMNICELL, Inc Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Mimecast Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G ESSENTIAL PROPERTIES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Freeline Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G TCR2 THERAPEUTICS INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G Aligos Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A ARENA PHARMACEUTICALS Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A PhaseBio Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A SVMK Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A NanoString Technologies Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A bluebird bio, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Affinivax Announces $226 Million Series C Financing to Advance Its Pipeline of Novel MAPS™ Vaccines Targeting Infectious Diseases
-
Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing
-
EVBox Group Consolidates Its Global Leadership by Reaching the Milestone of 200,000 Installed Charge Ports Worldwide
-
Verve Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
-
John Hancock Hedged Equity & Income Fund Required Notice to Shareholders - Sources of Distribution Under Section 19(a)
-
Perella Weinberg to go public via $975-million deal with Betsy Cohen's SPAC
-
Perella Weinberg to Merge with SPAC FinTech Acquisition Corp. IV (FTIV)
-
Current becomes first fintech to receive government stimulus payments
-
Perella Weinberg Partners and FinTech IV Announce Execution of Definitive Business Combination Agreement
-
Stock-picking hedge funds land investors double-digit gains in 2020
-
Esports Player Skillz to Merge with SPAC Flying Eagle Acquisition (FEAC) to Come Public
-
Skillz Becomes First Publicly-Traded Mobile Esports Platform
-
CIIG Merger Corp. Announces Filing of a Registration Statement on Form F-4 by Arrival Group in Connection With Its Proposed Business Combination With Arrival S.à r.l.
-
ESCAPE Bio Appoints Edward Owens and Scott Morrison to Board of Directors
-
EVBox Group to Become Public Company via Business Combination with TPG Pace Beneficial Finance (TPGY)
-
EVBox Group to Become Public Company via Business Combination with TPG Pace Beneficial Finance
-
Cityblock Health Raises $160M Series C to Address Systemic Healthcare Inequity
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A GLYCOMIMETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A TANDEM DIABETES CARE Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Syndax Pharmaceuticals Filed by: WELLINGTON MANAGEMENT GROUP LLP

